Molecular Cloning of the Wilms tumor Gene from 7p15-21
Molecular Cloning of the Wilms tumor Gene from 7p15-21
批准号:
6785508
负责人:
KHALID SOSSEY-ALAOUI
金额:
$18.92万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-08-01 至 2006-07-31
关键词:
Wilms&apos tumorbiotechnologydisease /disorder etiologygene deletion mutationgene expressionhigh performance liquid chromatographyhuman genetic material taghuman tissueloss of heterozygositymolecular cloningneoplasm /cancer geneticsnucleic acid denaturationpolymerase chain reactionserial analysis of gene expressiontumor suppressor genes
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Wilms tumor is pediatric lesion of the kidney and is one of the most common solid malignancies of the childhood. Disease can occur in one or both kidneys, approximately 8% of cases being bilateral. The suggestion of a genetic component in the etiology of the tumor has come from several observations. Firstly, bilateral disease is associated with an early age of onset. Secondly, there is a high incidence of bilateral tumors in cases with a family history of Wilms tumor and in patients with associated congenital anomalies. Histological features indicate that the tumor occurs as a result of aberrant embryological development of the kidney. The kidney is therefore a model for studying the association between processes involved in tissue development and predisposition to malignancy. Although a gene for Wilms tumor (WT1) has been cloned, less than 10% of cases could be explained by mutations and/or alterations of this gene. Several other loci have been implicated in the etiology of Wilms tumors, including the 7p15-21 locus which was shown to be involved in 15-25% of Wilms tumors cases, strongly suggesting that a tumor suppressor gene for this disease must lie within this region. Since homozygous deletions are hallmarks of tumor suppressor genes, a homozygous deletion has been described in a Wilms tumor within the 7p15-21 locus and we have now characterized the extent of this deletion as a first step towards the identification of the Wilms tumor suppressor gene using a very powerful mutation analysis technology (DHPLC) and a large cohort of Wilms tumors, including those tumors that we have identified to show loss of heterozygosity at the 7p15-21 locus. By studying the expression pattern of this gene we will be able to identify the population of stem cells which give rise to these tumors. Understanding the nature of the genetic events which allow these cells to escape their normal growth regulation may also provide an opportunity for therapeutic intervention.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Role of YB1 in health disparities in triple negative breast cancer
-
批准号:10655943
-
项目类别:
-
资助金额:$48.16万
-
财政年份:2023
-
负责人:KHALID SOSSEY-ALAOUI
-
依托单位:
Role of WAVE3 in the Development and Progression of Breast Cancer
-
批准号:10615730
-
项目类别:
-
资助金额:$36.09万
-
财政年份:2018
-
负责人:KHALID SOSSEY-ALAOUI
-
依托单位:
Role of WAVE3 in the Development and Progression of Breast Cancer
-
批准号:10400050
-
项目类别:
-
资助金额:$40.7万
-
财政年份:2018
-
负责人:KHALID SOSSEY-ALAOUI
-
依托单位:
Molecular Cloning of the Wilms tumor Gene from 7p15-21
-
批准号:6684394
-
项目类别:
-
资助金额:$17.37万
-
财政年份:2003
-
负责人:KHALID SOSSEY-ALAOUI
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于“Healthy-NAT-Tumor”三维度的食管鳞癌蛋白组学数据挖掘及其临床意义研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:刘伟
-
依托单位:
超级增强子驱动“CYTOR-FOSL1正反馈环路”促进口腔鳞癌Tumor budding转移的研究
-
批准号:82073265
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:王成
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
STAU1/TP63信号轴介导TINCR调控舌鳞癌tumor budding细胞干性维持
-
批准号:81802704
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:庄泽航
-
依托单位:
基于tumor cord-PBPK偶联模型的抗肿瘤药物药动学预测研究
-
批准号:81703454
-
项目类别:青年科学基金项目
-
资助金额:20.1万元
-
批准年份:2017
-
负责人:吴春暖
-
依托单位:
SUZ12 ceRNAs参与miR-320a调控舌鳞癌tumor budding侵袭转移的分子机制
-
批准号:81602380
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2016
-
负责人:谢楠
-
依托单位:
FOSL1 ceRNA网络调控舌鳞癌Tumor Budding细胞侵袭转移的分子机制
-
批准号:81572661
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2015
-
负责人:王成
-
依托单位: